Back
Erasca, Inc. ERAS · Insights
Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on ... Price15.61
Market Cap5.46 B
Float247.18 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro